Medicare Enrolled

Dr. Gary Ozier, M.D.

Family Medicine · Wichita Falls, TX
Low-engagement
4245 KEMP BLVD STE 420, Wichita Falls, TX 76308
9403227113
In practice since 2006 (20 years)
NPI: 1922086065 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ozier from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ozier? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ozier

Dr. Gary Ozier is a family medicine specialist in Wichita Falls, TX, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Ozier received a total of $5,314 from 29 pharmaceutical and/or device companies across 313 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ozier is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice $5,314 industry payments

Industry Payment Transparency

Open Payments through 2021 ↗
$5,314
Total received (2018-2021)
Avg $1,329/year across 4 years
Top 12% in TX for family medicine
29
Companies
313
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,314 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2021
$960
2020
$1,325
2019
$1,284
2018
$1,745

Payments by company (2021)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$1,066
Lilly USA, LLC
$738
AstraZeneca Pharmaceuticals LP
$508
Merck Sharp & Dohme Corporation
$405
Amarin Pharma Inc.
$392
GlaxoSmithKline, LLC.
$379
Boehringer Ingelheim Pharmaceuticals, Inc.
$367
SANOFI-AVENTIS U.S. LLC
$267
Janssen Pharmaceuticals, Inc
$179
PFIZER INC.
$132
Avanir Pharmaceuticals, Inc.
$123
Takeda Pharmaceuticals U.S.A., Inc.
$119
Allergan Inc.
$116
Astellas Pharma US Inc
$108
Novartis Pharmaceuticals Corporation
$72
Amgen Inc.
$54
Tris Pharma Inc
$49
Philips Electronics North America Corporation
$38
Circassia Pharmaceuticals Inc
$28
Allergan, Inc.
$27
AbbVie Inc.
$25
Synergy Pharmaceuticals Inc
$23
Lundbeck LLC
$19
Biohaven Pharmaceuticals, Inc.
$18
Purdue Pharma L.P.
$13
Medtronic MiniMed, Inc.
$12
Vertical Pharmaceuticals, LLC
$12
Genentech USA, Inc.
$12
Ironshore Pharmaceuticals Inc.
$11
Top 3 companies account for 43.5% of total payments
Associated products mentioned in payments ›
ANORO · ANORO ELLIPTA · Aimovig · Amitiza · BASAGLAR · BELSOMRA · BREO · BREZTRI · CHANTIX · DALVANCE · Dyanavel XR · ELIQUIS · EMGALITY · ENTRESTO · FARXIGA · INVOKANA · Ingenia 1 5T R5 · JANUVIA · JARDIANCE · Jornay PM 20mg capsules (Bottle of 100) · MYRBETRIQ · NUEDEXTA · NURTEC ODT · OFEV · Ozempic · PNEUMOVAX 23 · PREVNAR - 13 · ProxiDiagnost N90 C · QUILLICHEW ER · RELEXXII · RYBELSUS · Repatha · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYMPROIC · Saxenda · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · Tresiba · Trulance · UBRELVY · VIIBRYD · VYEPTI · Vascepa · Victoza · XARELTO · Xofluza · Xultophy 100/3.6 · ZOSTAVAX · iPro2
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a family medicine specialist in Wichita Falls?
Compare family medicine physicians in the Wichita Falls area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
96
Per 100K population
73.9
County median income
$62,168
Nearest hospital
NORTH TEXAS STATE HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2021
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ozier is a family medicine specialist, with low-engagement industry engagement in the top 12% of TX peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Ozier receive payments from pharmaceutical companies?
Yes. Dr. Ozier received a total of $5,314 from 29 companies across 313 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Ozier) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →